Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EnBrace HR for Premenstrual Syndrome (PMS) With Prominent Mood Symptoms (or Menstrual Related Mood Disorders, MRMD)

NCT04123483 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04123483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04123483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EnBrace HR for Premenstrual Syndrome (PMS) With Prominent Mood Symptoms (or Menstrual Related Mood Disorders, MRMD)
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Withdrawn
Start date
November 30, 2019
Completion date
November 30, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

menstrual related mood disorder, premenstrual dysphoric disorder, premenstrual syndrome, premenstrual tension